Munich Re Ventures

Munich Re Ventures Research Overview Munich Re Ventures (MRV) is the corporate venture capital arm of Munich Re, one of the world's largest reinsurance companies. Founded in 2015, the firm has deployed approximately $1.2 billion across nearly 100 investments over its 10-year history. However, as of October 2025, Munich Re announced a strategic shift ending new investments through Munich Re Ventures, consolidating the venture capital operation into MEAG (Munich Re's asset management arm) beginning in Q2 2026. Investment Thesis Munich Re Ventures' core thesis centers on "Funding the future of risk for the human endeavor." The fund operates at the intersection of technology, venture capital, and insurance, focusing on technologies and business models that tackle the biggest risks facing the world. MRV provides not just capital but deep market insights, industry expertise, and access to a curated global network of industry leaders in risk-related sectors. The firm's thesis is grounded in several key differentiators: Deep Industry Expertise : Leveraging decades of Munich Re's experience in insurance, reinsurance, and risk management Strategic Asset Management : Backed by Munich Re, a $1.2 billion fund provides substantial financial depth Industry Network Access : Unparalleled connections to organizations critical to success at the intersection of risk and technology, including design partners, customers, and strategic partners Long-term Alignment : Commitment to ongoing guidance and support from early stage through scale Munich Re Distribution & Services : Access to distribution channels, unique risk solutions, technical expertise, insurance capacity, and project finance Focus Areas Munich Re Ventures invests across five primary investment areas: 1. Insurtech Focuses on changing how insurance is delivered, how risks are assessed, and how losses are mitigated. Notable companies include Next Insurance (acquired by Munich Re for $2.6B in 2019), At-Bay (cyber insurance, valued at $1.35B+), Faye (travel insurance), Capitola, Insify, and INSHUR. 2. Cybersecurity & Privacy Companies assessing, quantifying, and reducing cyber risks. Portfolio includes At-Bay, Sweet Security, Ghost Security, Abstract Security, and Sepio Systems. 3. HealthTech Companies focused on understanding health risks and helping people live longer, healthier lives. Portfolio includes Future Family (fertility/IVF, $400M+ invested), Babylon Health, Air Doctor, and Quantile Health. 4. Resilient Future (Climate & Energy) Investing in the future of energy, infrastructure, and planetary resilience. Portfolio includes Zanskar (geothermal energy discovery), Twelve (sustainable aviation fuel), Found Energy (low-carbon energy), VEIR (superconducting solutions), and Runwise (smart building operating system). 5. Built World (Property, Industry & Supply Chain) Equipment and technology to de-risk and optimize performance in property, industry, and supply chains. Portfolio includes ShipIn Systems (AI-powered fleet management), Augury (machine health detection, $1B+ valuation), Sixfold (supply chain optimization), Inspectify, Appraisify, and MPC Container Ships. Portfolio Highlights Munich Re Ventures has invested in over 50 portfolio companies, with several reaching unicorn status or acquisition: Notable Exits & Acquisitions: Next Insurance: Acquired by Munich Re for $2.6 billion (2019) - digital insurance platform for small businesses Hippo Insurance: Became publicly traded through SPAC merger (2021) - home insurance platform At-Bay: Valued at $1.35B+ - cyber insurance specialist Babylon Health: Raised $550M+ at $2B+ valuation - AI-based health services Augury: Machine health detection AI, valued at $1B+ Trov: Acquired by Travelers (2023) - on-demand insurance platform Active Portfolio (50+ companies): Faye (travel insurance, $31M Series B) Future Family (fertility investment platform, $400M+ forward flow) Zanskar (geothermal energy, $30M Series A) Twelve (sustainable aviation fuel, $645M+ funding) SPAN (smart electrical panel, $96.5M Series B2) Starfish Space (satellite servicing, $29M) Orbit Fab (in-space refueling, $10M+) ShipIn Systems (AI fleet management) Augury (machine health AI) Ghost Security (API security) Sentra (cloud data security, $50M Series B) And 40+ additional portfolio companies Recent Activity & Fund Status Critical Update (October 2025): Munich Re announced the cessation of new investments through Munich Re Ventures. The strategic decision reflects Munich Re's shift to concentrating innovation within core businesses. Timeline: October 27, 2025 : Munich Re announces MRV will cease new investments Q2 2026 : Transition complete; small team oversight moves to MEAG (asset management arm) Beyond Q2 2026 : Skeleton team in San Francisco manages existing portfolio and supports founders Recent (2025) : Mechanical Orchard investment (IT legacy modernization), HSB fund anniversary celebration, $125M new fund from HSB Fund Activity: Fund II ($500M, closed 2021): Actively deploying HSB Fund ($125M, 2025): Leveraging specialized insurance programs ERGO Fund: Focused on specific insurance segments General investment trend: Focused on portfolio support and existing investments Team & Leadership Munich Re Ventures operates with over 70 years of combined venture capital experience across a team of 40+ professionals: Key Leadership: Oshri Kaplan : Managing Director (Insurtech, Cybersecurity & Privacy) Alex Kamenetskiy : Managing Director, COO/CFO Ian Sanders : SVP Portfolio Development Directors: Sidra Ahmed Lefort : Director (HealthTech, Cybersecurity & Privacy) Timur Davis : Director (Resilient Future, Built World) Ben Bergsma : Director (Insurtech, HealthTech) Principals & Operational Leadership: Peter Volz : General Counsel Pedro Carrasco : Head of Operations and Technology Jill Richardson : Head of Marketing The team covers multiple investment areas with deep expertise, and many professionals have backgrounds from major insurance companies, tech firms, and previous venture funds. Investment Criteria & Preferences Stage Preferences: Primarily Seed and Series A, with selective pre-seed investments in exceptional technical founders Check Size Range: $500K - $10M (based on existing data) Decision Process: Partnership model with director-level involvement Lead Tendency: MRV often leads or co-leads investments, but increasingly focuses on supporting existing portfolio companies rather than new deployments Warm Intro Required: Preferred for deal flow Geographic Focus: Primarily US (San Francisco, NYC), with selective investments in Europe (UK, Germany), Israel, and Asia-Pacific Founder Preferences: Technical founders with domain expertise in risk-related sectors; founders solving real problems at the intersection of insurance and technology Strategic Context & Market Position Munich Re Ventures operates within a unique position as a corporate venture arm backed by one of the world's largest reinsurers. Key advantages include: Access to Insurance Ecosystem : Unmatched connections to insurance company relationships, reinsurers, and industry leaders Risk Expertise : Deep understanding of insurance underwriting, risk assessment, and loss mitigation Distribution Potential : Portfolio companies can leverage Munich Re's global distribution network Financial Strength : Access to substantial capital and patient financing Strategic Support : Beyond capital, companies gain operational support, customer introductions, and risk expertise Strategic Shift & Current Status As of late 2025, Munich Re has undergone a strategic realignment focusing innovation efforts directly within core business units rather than through external venture investments. This reflects broader trends in corporate venture capital consolidation and a return to organic innovation models. Impact on Portfolio: Existing investments will continue to receive support Small team in San Francisco will manage assets through MEAG Innovation sourcing will shift to Munich Re's business divisions No new investments from Munich Re Ventures after Q2 2026 Conclusion Munich Re Ventures built an impressive portfolio of 50+ companies over 10 years, generating significant financial returns and strategic value for the parent company. While the fund is transitioning to a wind-down operation, the existing portfolio reflects a well-executed strategy focused on the intersection of insurance and technology. The firm's legacy includes several unicorn-level exits and a demonstrated ability to identify and support transformative technologies in risk management.